Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Dance for Parkinson's Disease® (DfPD®) is a structured dance program that has never been evaluated in Greek PD population. This study assesses for the first time the efficacy, safety and feasibility of DfPD® program in Greek PD patients.
A total of 16 early-to-mid-stage PD patients underwent a total of 16 60-min classes of adjusted to Greek music and dance culture DfPD®, twice weekly, over 8 weeks. Assessments were performed at baseline and at the end of the study period and included quality of life, depressive symptoms, fatigue, cognitive functions, balance and body mass index. Safety and feasibility were also assessed.
Parkinson's Disease (PD) is an idiopathic, neurodegenerative, and progressive movement disorder caused mainly by dysfunction of dopaminergic cells of the substantia nigra. Numerous studies demonstrate the benefits of regular physical exercise in PD, with aerobic exercise having a greater neuroprotective effect by stimulating brain neuroplasticity. People with PD are more easily motivated to attend dance classes systematically than other forms of exercise, they have a high compliance rate with low dropouts, and often continue to practice dance outside the dance intervention.
DfPD® (Dance for Parkinson's Disease®, or Dance for PD®) was developed by the Brooklyn Parkinson Group (BPG) in collaboration with the Mark Morris Dance Group (MMDG) in 2001.This intervention has previously been shown to exert beneficial effect on QoL, motor functions, cognition, self-efficacy, anxiety and depression in people with PD. To the investigators' knowledge, there is no study investigating the effect of any structured dance program in Greek PD patients. Furthermore, no study to date has investigated the effect of DfPD® on PD patients' fatigue. The present pilot study aimed at evaluating for the first time the efficacy, safety and feasibility of a culturally adjusted DfPD® program in Greek patients with early-to-mid-stage PD.
This is a prospective, non-randomized, uncontrolled, open-label, pilot study. A total of 16 early-to-mid-stage PD patients underwent a total of 16 60-min classes of adjusted to Greek music and dance culture DfPD®, twice weekly, over 8 weeks. Assessments were performed at baseline and at the end of the study period and included quality of life, depressive symptoms, fatigue, cognitive functions, balance and body mass index. Safety and feasibility were also assessed.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Dance for PD® classes | Experimental | Dance for PD® was developed by the Brooklyn Parkinson Group (BPG) in collaboration with the Mark Morris Dance Group (MMDG) in 2001. It was designed to introduce people with PD to techniques used by dancers to control movement and it integrates different dance genres while participants dance individually and in groups rather than partnered. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Dance for PD® classes | Behavioral | The intervention consisted of 16 60-min classes, performed twice weekly over a period of 8 weeks and instructed by a single researcher who had the approval to use it for research reasons. |
| Measure | Description | Time Frame |
|---|---|---|
| Change in total score of Parkinson's Disease Questionnaire-8 | Minimum score 0, Maximum score 100. A higher score indicates worse quality of life. | Baseline (week 1), end of intervention (week 10) |
| Occurence of Emergent Adverse Events | Occurrence of adverse events comprising falls, injuries, muscle soreness or excessive fatigue. | During the intervention (week 2-9) |
| Financial Feasibility Assessment | No cost for the studio and the dance instructor. | During the intervention (week 2-9) |
| Adherence and Attrition Assessment | Adherence and attrition rates; an adherence rate ≥70% is considered as high in elderly with functional limitations, and attrition rate ≤15% is considered acceptable by the PEDro scale. | During the intervention (week 2-9) |
| Assessment of Willingness to Continue the Program after the Intervention | Verbal statement for continuing the program after the end of the intervention | End of intervention (week 10) |
| Assessment of Recruitment Rates | Target, up to 2 months for 16 participants. | Start of Recruitment (-3 months), Baseline (week 1) |
| Measure | Description | Time Frame |
|---|---|---|
| Change in total score of Beck Depression Inventory-II | Minimum score 0, Maximum score 63. A higher score indicates worse depressive symptoms. | Baseline (week 1), end of intervention (week 10) |
| Change in total score of Parkinson Fatigue Scale-16 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Michail Elpidoforou, MSc | Laboratory of Neuromuscular and Cardiovascular Study of Motion (LANECASM) | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Laboratory of Neuromuscular and Cardiovascular Study of Motion (LANECASM) | Athens | Attica | 12243 | Greece |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010300 | Parkinson Disease |
| D003863 | Depression |
| D005221 | Fatigue |
| ID | Term |
|---|---|
| D020734 | Parkinsonian Disorders |
| D001480 | Basal Ganglia Diseases |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Minimum score 1, Maximum score 5. A higher score indicates more fatigue.
| Baseline (week 1), end of intervention (week 10) |
| Change in total score of Montreal Cognitive Assessment | Minimum score is 0, Maximum score 30. Lower scores indicate cognitive impairment. | Baseline (week 1), end of intervention (week 10) |
| Change in total score of Berg Balance Scale | Minimum score is 0, Maximum score is 56. Lower scores indicate worse balance. | Baseline (week 1), end of intervention (week 10) |
| Change in Body Mass Index | Lower scores than 18,5 indicate underweight, scores of 18,5-24,9 indicate normal weight, scores of 25-29,9 indicate overweight and scores of over 30 indicate obesity. | Baseline (week 1), end of intervention (week 10) |
| D009422 | Nervous System Diseases |
| D009069 | Movement Disorders |
| D000080874 | Synucleinopathies |
| D019636 | Neurodegenerative Diseases |
| D001526 | Behavioral Symptoms |
| D001519 | Behavior |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |